Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Brady

Showing results (321-330 of 376) with videos related to

Pageof 38
Sort By:
European Journal of Biochemistry|August 15, 1983
Monoclonal antibodies against human beta-glucocerebrosidaseR A Barneveld, F P Tegelaers, E I Ginns, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry miceS C Jung, I P Han, A Limaye, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2012
β-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomasChunzhang Yang, Rajiv R Iyer, Albert C H Yu, et al.
Biochimica Et Biophysica Acta|June 5, 1991
Type C Niemann-Pick disease: cellular uncoupling of cholesterol homeostasis is linked to the severity of disruption in the intracellular transport of exogenously derived cholesterolC E Argoff, M E Comly, J Blanchette-Mackie, et al.
Stroke|February 2, 2002
Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacementDavid F Moore, Gheona Altarescu, Geoffrey S F Ling, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
alpha-Galactosidase A deficient mice: a model of Fabry diseaseT Ohshima, G J Murray, W D Swaim, et al.
Pediatrics|September 5, 2006
Enzyme-replacement therapy with agalsidase alfa in children with Fabry diseaseMarkus Ries, Joe T R Clarke, Catharina Whybra, et al.
The Journal of Pediatrics|February 1, 1992
Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher diseaseN W Barton, R O Brady, J M Dambrosia, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomesE J Blanchette-Mackie, N K Dwyer, L M Amende, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2010
Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-CblJie Lu, Jeffrey Chiang, Rajiv R Iyer, et al.
Pageof 38

Showing results (321-330 of 376) with videos related to

Sort By:
Pageof 38
European Journal of Biochemistry|August 15, 1983
Monoclonal antibodies against human beta-glucocerebrosidaseR A Barneveld, F P Tegelaers, E I Ginns, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry miceS C Jung, I P Han, A Limaye, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2012
β-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomasChunzhang Yang, Rajiv R Iyer, Albert C H Yu, et al.
Biochimica Et Biophysica Acta|June 5, 1991
Type C Niemann-Pick disease: cellular uncoupling of cholesterol homeostasis is linked to the severity of disruption in the intracellular transport of exogenously derived cholesterolC E Argoff, M E Comly, J Blanchette-Mackie, et al.
Stroke|February 2, 2002
Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacementDavid F Moore, Gheona Altarescu, Geoffrey S F Ling, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
alpha-Galactosidase A deficient mice: a model of Fabry diseaseT Ohshima, G J Murray, W D Swaim, et al.
Pediatrics|September 5, 2006
Enzyme-replacement therapy with agalsidase alfa in children with Fabry diseaseMarkus Ries, Joe T R Clarke, Catharina Whybra, et al.
The Journal of Pediatrics|February 1, 1992
Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher diseaseN W Barton, R O Brady, J M Dambrosia, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomesE J Blanchette-Mackie, N K Dwyer, L M Amende, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2010
Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-CblJie Lu, Jeffrey Chiang, Rajiv R Iyer, et al.
Pageof 38